Stroma Biosciences co-founders have been accepted as the cover story in Science Translational Medicine for their work on the tumour microenvironment. The research found that treating the normal cells near to the cancer cells with small molecule inhibitors significantly improved the effects of a broad range of chemotherapies
https://www.science.org/doi/10.1126/scitranslmed.aax9340